GPT and cancer: Loss of the telomere-binding protein POT1 – which regulates the 5’ end sequence at the end of chromosomes in ALT-negative cells (Hockemeyer et al., 2005) – also altered the telomere sequence of cancer cells that rely on the ALT pathway.